David Munn, MD
Medical College of Georgia at Augusta University
Catapult Award: 2023-2025
Focus: Pediatric Brain Tumors; Immunotherapy; Novel Agent, Combination Therapy
Project title: Combined IDO and BTK Inhibition for Immunotherapy of Pediatric Brain Tumors

This project is supported in part by the Rally Foundation for Childhood Cancer Research.
"We chose brain cancer because it was a completely understudied or underserved field. Until today, there’s just no accepted standard pathway to deal with any relapse brain cancer. So it was a population of patients who seemed best positioned to benefit from new modalities of therapy."